chrisvoncsefalvay/vaers-outcomes huggingface dataset:
tiny blister rash; Rash lips; Blistery rash; This case was reported by a consumer via call center representative and described the occurrence of lip blister in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   In October 2019, the patient received the 1st dose of Shingrix. In October 2019, less than a day after receiving Shingrix, the patient experienced lip blister, rash lips and blistery rash. The patient was treated with cortisone (non-proprietary) (Cortisone Cream), ascorbic acid,betacarotene,lysine hydrochloride,zinc amino acid chelate (Cold Sore (Ascorbic Acid + Betacarotene + Lysine + Zinc Amino Acid Chelate)) and neosporin (nos) (Neosporin). On an unknown date, the outcome of the lip blister, rash lips and blistery rash were not recovered/not resolved.   It was unknown if the reporter considered the lip blister, rash lips and blistery rash to be related to Shingrix.  Additional details were provided as follows:  The age at vaccination was not reported. The age group was not reported but was selected adult as per vaccine indication.  The patient experienced tiny blister rash that comes and goes under bottom lip, after receiving 1st dose of Shingrix. It was been over a month since patient had this shot. The reporter wanted to know how could get rid of it as it was very ugly and what should be put on it.
Urinary Tract Infection-antibiotics 10 days, Elbow swollen Napracin 7 days, Severe aches -ongoing since 04/02 (Doxyclene), Dizziness- Moderate to Severe Global Heterogenous Hypoperfection / Lesion on Brain also (MRI), Tingling and numbness-has gone away, Tachycardia - Toprol if needed- Optic Nerve problem.
She woke up normal, she went to her room for her prayers and that's when she fell out of her chair with a stroke. She was brought to the hospital immediately and was confirmed to have had blood clot in her brain. She was hospitalized from 11/09/2021 and passed away on 11/19/2021.
This spontaneous report as received from a 67 years old female patient regarding herself. The patient was allergic to penicillin. The patient had no medical history. On 07-DEC-2012, the patient was vaccinated with first dose of ZOSTAVAX (lot number, expiry date and dose were not reported) subcutaneously on her left arm. Concomitant medications were none. On 07-DEC-2012, the patient experienced pain at the site on her left arm. Later on 12-DEC-2012, the patient developed a rash type symptom on her trunk, on her hip and back not on one side of her body. She described it as diffused and as red spots. The patient sought no medical attention and no treatment was provided. The outcome of all the reported events was unknown. Additional information is not expected.
Nov. 2, 2009 - 11:00 A.M. - Regular flu shot received at pharmacy. Instructions from nurse - go home and take a nap; was unable to sleep. Approximately 1 1/2 to 2 hours later, throat began to swell, coughing, runny nose and eyes. Intense for 24 hours and then lessened. Nov. thru April, 2010 - experienced sinus pain and pressure, coughing, nose bleed, nausea, spells of diarrhea and constant mucus draining from sinus. May - Nose bleed and diarrhea ended. Throat got worse with loss of voice, coughing and mucus drainage continued. June - Throat eased up, mucus continued and annual hives began a month earlier than usual. Tried allergy pills but felt worse. July - Symptoms continued. August - Severe attack on throat; lost voice for several days; was unable to talk much the entire month; when I finally got my voice back was only able to say a few sentences before coughing would begin. September - Symptoms continued with diarrhea returning and addition of fall allergies which will last until heavy frost and they will, literally, disappear overnight. Mucus is clear; temperature ranges from 97 degrees to 98 degrees; purchased BP monitor and BP has been in the 116 to 125 over 75 to 80 range; have no discomfort in chest. CONCLUSION: NO MORE FLU SHOTS!!!  October & November - Occasional flare-up of above symptoms which lessened as the months went by. Saw chiropractor on 11/3/10 and he was pleased with the progress I've made. He said that symptoms may last more than a year.
achiness; soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (achiness) and MYALGIA (soreness) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     Concomitant products included CITALOPRAM for an unknown indication.    On 21-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Feb-2021, the patient experienced PAIN (achiness). 21-Feb-2021, the patient experienced MYALGIA (soreness). On 22-Feb-2021, PAIN (achiness) and MYALGIA (soreness) had resolved.            No concomitant information was reported. No treatment information was reported.   This case was linked to MOD-2021-418844, MOD-2021-418822 (Patient Link).
8/8/03 increased pain in left thigh, mild swelling. 8/10/03 much improved.
Severe muscle fatigue, joint pain & swelling x 48 hrs nausea/vomitting x 24 hrs.
About two hours after receiving the Pfizer vaccine shot #1, my left arm became numb and stiff, starting at my wrist and worked up my upper arm. I could not lift my left arm at all, but when I tried, the pain was severe and radiated over the left half of my chest and over my heart.  I thought this might be a passing reaction, and went to bed early. My condition was the same in the morning, and I contacted my doctor, who directed me to go to the emergency room or to Urgent Care, which I did.
Patient was given Pfizer comirnaty 12yrs and old Patient is 5yrs old at time of vaccination
PATIENT EXPERIENCED REDNESS AND SWELLING EVENING AFTER  RECEIVING. SHE WENT TO THE DOCTOR AND WAS DIAGNOSED WITH CELLULITIS, WAS PRESCRIBED ANTIBIOTIC.
This spontaneous report as received from a pharmacist refers to an adult (exact age not specified) patient of unknown gender. Medical history and drug reactions or allergies were not specified. On an unknown date, reported as a couple of years ago, the patient was vaccinated with the first dose of VARIVAX (dose, route and lot number were not reported). Concomitant medications were not specified. On 17-SEP-2014, reported as currently, the patient was at the office to received their second dose of VARIVAX (dose, route and lot number were not reported). No adverse effect was reported. Additional information has been requested.
It started when I woke up with a tight throat. I started feeling some sinus pressure as well but also got on a plane that day so I felt it stronger. I took a home COVID test and it was negative. The next day from travelling, I had additional cold symptoms that dealt with sinus congestion. I think I also had a bit of a cough and a headache. On the 11th and the 12th of March I took another test and that one was positive. I developed on these days a mild fever and fatigue. I called the doctor on the 13th and was given Paxlovid and I took the 5 day course. Symptoms continued to be mild cold like symptoms through the week and was able to continue my normal daily life. On the 17th I took a test and was negative and have been negative since.
11 days after the 2nd vaccine, I started having tremors, anxiety and insomnia.
Administered vaccine that was stored at temperature between -80 degree F to -84 degree F; Administered vaccine that was stored at temperature between -80 degree F to -84 degree F; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) and POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 076C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Nov-2021 at 1:59 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 04-Nov-2021 at 1:59 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F). At the time of the report, PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) and POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were reported.  Patients were given doses from vials that were stored in an ultracold freezer which is colder than they should have been. The vial undergone temperature excursions for 1 month. The vial was in frozen state at the time of the excursion. The vials moved from freezer to refrigerator on 19 Nov 2021. The maximum and minimum reached temperatures was negative 82 degrees Fahrenheit. The vials were returned to the freezer or refrigerator or maintained at room temperature. The reporter stated that total 70 vials were still in the ultra-cold freezer and 8 vials were in the refrigerator. No vaccine state changes were noticed. The vaccine was never refrozen. None of the vials were punctured. No previous temperature excursion issues had happened.  No treatment information was provided by the reporter.   This case was linked to MOD-2021-402935 (Patient Link).
Nausea first 2 days; Foggy head and headache first 2 days; Extreme tiredness first 2 days; Achiness first 2 days; Very sore arm for 1 week; Swelling, redness, fever and rash at/around site of shot on left arm lasting 3-4 days; Extreme constipation began 2 days after shot and lasted 4 days, followed by diarrhea for 2 days after that; overall duration of side effects lasted for one week.
reported itching & soreness @ site of inj;onset 24hr p/vax;instructed to take APAP as needed & to use ice pack to site;
Sleeplessness, went to bed and felt like an adrenaline rush all night.  No chills or fever or soreness, just no sleep.  Only slept for a few 20 to 45 minute intervals throughout the night.  Feeling fine today.
period turned extremely heavy/now her period lasts 9 days; hands turn blue and feels like ice and cold and they feel numb; hands turn blue and feels like ice and cold; hands turned completely blue; circulatory issues; This is a spontaneous report received from a contactable reporter(s) (Nurse) from medical information team. The reporter is the patient.  A 36-year-old female patient received BNT162b2 (BNT162B2), on 10Nov2021 as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: SKIN DISCOLOURATION (non-serious) with onset 11Nov2021, outcome "unknown", described as "hands turned completely blue"; CARDIOVASCULAR DISORDER (non-serious) with onset Nov2021, outcome "not recovered", described as "circulatory issues"; HEAVY MENSTRUAL BLEEDING (non-serious), outcome "not recovered", described as "period turned extremely heavy/now her period lasts 9 days"; HYPOAESTHESIA (non-serious), outcome "unknown", described as "hands turn blue and feels like ice and cold and they feel numb"; PERIPHERAL COLDNESS (non-serious), outcome "unknown", described as "hands turn blue and feels like ice and cold".  Additional information: She had her first dose on 10Nov2021, and she states 24 hours later her hands turned completely blue and she has continued to have circulatory issues since. Reports that her period turned extremely heavy, she used to have as a regular period, just moderate, and now her period lasts 9 days and was heavy the entire time. The caller's hands turn blue and feels like ice and cold and like neuropathy and they feel numb. This has all happened since her first vaccination. Caller did get the second dose but was forced to do that if she didn't get it she would be fired and her second dose was 16Apr2022.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
FORGOT TO TAKE LAST DOSE; This spontaneous case (PVX2019-1043) was received from a caregiver on 27-Apr-2019. It describes a female consumer who "forgot to take last dose", while being on Vivotif capsule for an unknown indication.  Case report: The consumer took the first three Vivotif doses on 20-Apr-2019, 22-Apr-2019, and 24-Apr-2019 respectively. She forgot to take the last dose, which was due on 26-Apr-2019.  Action taken with Vivotif was not applicable.  The clinical outcome of the event "forgot to take last dose" was unknown.  Company's Comment: The causality of the event "forgot to take last dose" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "forgot to take last dose" was considered as not applicable.
17 year old patient received their first dose of Moderna at mass vaccination site the previous month.  Patient presented at mass vaccination site for second dose.  Guidance dictates that if patient has received first dose of Moderna, they should still receive second dose.  Second dose was administered with no problems/adverse outcome.  The only reason for submitting this VAERS report is due to a 17 y.o. patient receiving a Moderna dose.
Side effects; This case was reported by a consumer via call center representative and described the occurrence of adverse drug reaction in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced adverse drug reaction. On an unknown date, the outcome of the adverse drug reaction was unknown.   It was unknown if the reporter considered the adverse drug reaction to be related to Shingrix.  Additional details were provided as follows: This case was reported by the reporter for one of her friend. The age at vaccination was not reported. The reporter stated that the patient experienced side effects after vaccination. The reporter did not know what side effects the patient experienced. Reporter did not want to provide further further details. This case has been linked with case US2019202816, reported by the same reporter.
Severe lower intestinal pain, diarrhea, pain moved up through middle, pain continue all over stomach and intestinal area, extreme sweating, hot and cold chills, diarrhea continued until it was uncontrollable, nausea and dry heaving, sweat was dripping off me. All this was about 40 minutes before I could get back to bed. Oct 25th still have sore ribs from heaving, and the site of shot is still swollen and is now spread out 4 inches long.
patient experienced redness several inches in diameter in injection site.  It was warm to the touch and sore.  She approached the pharmacy 10 days after shot given to discuss what was going on.  She reached out to physician and she wanted to see her.  MD diagnosis was an infection and cephalexin was given
Rec'd. dose #3 GARDASIL (HPV-9) at WCE in office on 6-10-16. Woke next A.M. with c/o SA/stomach 'cramps'/and redness with edema and induration with warmth to (L) arm. Tx'd at home with BENADRYL. Seen for F.U. in office 6-13-16. S/S now nearly resolved and returned to WNL.
was exposed to covid a day before first dose and tested positive a week later after receiving the vaccine and patient was tested again yesterday and was still positive; patient was tested again yesterday and was still positive; This is a spontaneous report received from a contactable consumer (Patient) as part of Pfizer-sponsored program . A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection) via an unspecified route of administration as single dose for COVID-19 immunisation. Patient received  Cortisporin via unspecified route for unspecified indication. The patient medical history and concomitant medications were not reported. On an unspecified date, patient exposed to Covid a day before first dose and tested positive a week later after receiving the vaccine and patient was tested again yesterday and was still positive and wanted to know what to do about her second dose tomorrow. Patient underwent Lab test and procedure which included SARS-CoV-2 test positive in March. The outcome of the events was unknown.  Follow-up (04Apr2021): New information from spontaneous report received from a contactable consumer (patient) includes: Medical Information Potential AE.  Follow up (05Apr2021): New information from spontaneous report received from a contactable consumer (patient) includes: Suspect Product: Cortisporin  Information on the lot/batch number has been requested.
I26.94 MULTIPLE SUBSEGMENTAL PULMONARY EMBOLI WITHOUT ACUTE COR PULMONALE 11/15/2022 HYPOKALEMIA I26.99 ACUTE PULMONARY EMBOLISM 11/15/2022 HYPOKALEMIA I95.9 HYPOTENSION 11/15/2022 HYPOKALEMIA J96.11 CHRONIC HYPOXEMIC RESPIRATORY FAILURE 5/12/2022 HYPOKALEMIA R09.02 HYPOXIA 11/15/2022 HYPOKALEMIA I26.94 MULTIPLE SUBSEGMENTAL PULMONARY EMBOLI WITHOUT ACUTE COR PULMONALE 11/15/2022 HTN (HYPERTENSION) I26.99 ACUTE PULMONARY EMBOLISM 11/15/2022 HTN (HYPERTENSION) I95.9 HYPOTENSION 11/15/2022 HTN (HYPERTENSION) J96.11 CHRONIC HYPOXEMIC RESPIRATORY FAILURE 5/12/2022 HTN (HYPERTENSION) R09.02 HYPOXIA 11/15/2022 HTN (HYPERTENSION) I26.94 MULTIPLE SUBSEGMENTAL PULMONARY EMBOLI WITHOUT ACUTE COR PULMONALE 11/15/2022 LACTIC ACIDOSIS, UNSPECIFIED I26.99 ACUTE PULMONARY EMBOLISM 11/15/2022 LACTIC ACIDOSIS, UNSPECIFIED I95.9 HYPOTENSION 11/15/2022 LACTIC ACIDOSIS, UNSPECIFIED J96.11 CHRONIC HYPOXEMIC RESPIRATORY FAILURE 5/12/2022 LACTIC ACIDOSIS, UNSPECIFIED R09.02 HYPOXIA 11/15/2022 LACTIC ACIDOSIS, UNSPECIFIED
Information has been received from a current 56 year old female nurse, who in June 2006, when she was 52 year old was vaccinated SC with "1" dose of VARIVAX (Merck) (Lot # not reported). The consumer reported, that 21 days after receiving VARIVAX (Merck) in approximately June 2006 she developed zoster. She began to develop pain in the back of her right knee that radiated to her back. She also reported that "few days later" she developed a rash. The rash had resolved and the consumer had persistant pain for two month afterwards. On an unspecified date, the consumer was recovered. It was unknown if the patient sought medical attention. No further information is available.
Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 20-Jul-2022; No adverse event; Administered the vaccine to 346 patients after the 30 day by used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 20-Jul-2022) and NO ADVERSE EVENT (No adverse event) in a 71-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058A22-2A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 20-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 20-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 20-Jul-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 20-Jul-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used) and PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 20-Jul-2022).    Concomitant product use was not provided by the reporter.  Patient received half dose.  On 04-Jun-2022, the vials were initially stored in the refrigerator.  Vial did not undergone any temperature excursions.  Treatment information was not provided.
Systemic: Confusion-Mild, Systemic: Dizziness / Lightheadness-Mild, Systemic: Fainting / Unresponsive-Mild, Systemic: Hypotension-Mild, Additional Details: Pt received their covid shot and showed no issues/signs of rxn. When pt was going to stand up he fell over. 911 was immediately called since he sas unresponsive but eventually came around in a couple of minutes.  Placed pt on chair upon request, where he stated that this happens to him in healthcare settings and has happened before. Pt then started not feeling well and was kept upright by pharmacy staff and paramedics arrived.  paramedics stated his blood pressure was low.
Pt presented with acute onset of right vision loss. She was seen by ophthamology and diagnosed with central retinal artery occlusion. She had to be changed to warfarin as this clot developed while she was already on eliquis. She still has some vision loss.
chills all day; I've had vomit; nausea; high fever; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age (Age: 37; Unit: Unknown) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on 24Feb2021 (Batch/Lot number was not reported) as dose 2, single for COVID-19 immunisation.  The patient's medical history and concomitant medications were not reported. The patient previously took the first dose of BNT162B2 on an unspecified date for COVID-19 immunisation. On 24Feb2021, the patient experienced chills all day, since then I've had vomit, nausea, chills and high fever. The outcome of the events was not recovered/not resolved.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected.
Within about 1 minute after injection, Client stated that she felt light-headed and nauseous. Had her lie down in exam room. After about 30 minutes, she stated that she felt quite a bit better.   Also c/o's of numbness down side of arm where injection given.  All symptoms had improved but not totally gone when she said she felt well enough to leave the clinic. Will follow-up with her this afternoon.
Normal side affects felt: fever, chills, body aches. Felt by 5pm and lasted until the next morning ~0700. After symptoms broke, the feeling of sluggish occurred all next couple of days. Throughout, it seemed like I could not quench my thirst.  Additionally, red bumpy rash on my legs (mostly thighs) occurred and itching along with it on legs. Not enough to go to emergency room, but definitely uncomfortable. Took Benadryl to help. Subsided about a week later. At injection site, only bruise which I am guessing was from some abnormal bleeding that occurred at injection. I barely had any soreness in the arm.  Lastly, a feeling of inability to take a deep enough breath. A feeling of if I had vicks on my chest type cool feeling when I took a breath. The feeling has lingered until now, but not enough to cause any issue. I can breath, but not full deep breaths. Because it has been getting better every day, I imagine it will subside soon. I will go to doctor if it does not get better.